FDA Adverse Event Injury Summary report: N

ARTISAN

MDR report key: 7675697 · Received July 10, 2018

Report

Report Number
3006630150-2018-60086
Event Type
Injury
Date Received
July 10, 2018
Date of Event
June 14, 2018
Report Date
August 6, 2018
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT ONE OF THE PATIENTS LEADS FROM THE PADDLE WOULD NOT PLUGGED INTO THE NEW IPG. THE PATIENT UNDERWENT A REVISION PROCEDURE WHEREIN THE LEAD WAS REPLACED AND THE OTHER TWO LEADS WERE EXPLANTED. THE PATIENT WAS DOING WELL POSTOPERATIVELY. MODEL NUMBER/CATALOG NUMBER: SC-2135-50; SERIAL NUMBER: (B)(4); BATCH/LOT NUMBER : N/A; MODEL/CATALOG DESCRIPTION: PHASE III LINEAR LEAD - 50 CM. IT IS INDICATED THAT THE DEVICES WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICES COULD NOT BE COMPLETED. A REVIEW OF THE DEVICE HISTORY RECORDS WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MED WATCH WILL BE FILED.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT DURING THE PATIENTS IPG REPLACEMENT PROCEDURE (MFR REPORT #: 3006630150-2018-01008), THE PHYSICIAN COULD ONLY CONNECT ONE OF THE THREE LEADS TO THE IPG. THE PATIENT WILL UNDERGO A REVISION PROCEDURE WHEREIN THE OTHER TWO LEADS WILL BE CONNECTED.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT DURING THE PATIENTS IPG REPLACEMENT PROCEDURE (MFR REPORT #: 3006630150-2018-01008), THE PHYSICIAN COULD ONLY CONNECT ONE OF THE THREE LEADS TO THE IPG. THE PATIENT WILL UNDERGO A REVISION PROCEDURE WHEREIN THE OTHER TWO LEADS WILL BE CONNECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
515999 ARTISAN STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-8116-50 112576

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention